Partial Lipodystrophy Mimicking Cushing's Syndrome: Clinical and Metabolic Insights from a Multicenter Study

Area of Science:

• Endocrinology
• Metabolic Disorders
• Genetics

Background:

• Partial lipodystrophies (PLD) present clinical features overlapping with Cushing's syndrome (CS).
• Existing clinical risk scores for CS may lack specificity in differentiating these conditions.
• The influence of leptin on the hypothalamic-pituitary-adrenal (HPA) axis in lipodystrophy requires further investigation.

Purpose of the Study:

• To compare clinical and metabolic characteristics between PLD and CS.
• To assess the diagnostic accuracy of current clinical risk scores for CS in distinguishing it from PLD.
• To explore potential interactions between leptin and the HPA axis in patients with PLD.

Main Methods:

• A retrospective multicenter study involving 61 PLD patients and 56 CS patients.
• Collection and analysis of clinical and laboratory data from medical records.
• Calculation of two established clinical risk scores for CS and comparative analysis of patient features.

Main Results:

• PLD patients frequently displayed cushingoid features, including facial fullness, plethora, dorsocervical fat pads, and hirsutism.
• Proximal muscle atrophy and osteoporosis were more prevalent in CS patients.
• PLD was associated with higher incidences of diabetes and hypertriglyceridemia, while CS was linked to muscle atrophy and osteoporosis.

Conclusions:

• Cushingoid features are common in PLD, diminishing the specificity of simplified clinical risk scores for CS diagnosis.
• Distinguishing between PLD and CS requires heightened clinical suspicion and recognition of specific phenotypic differences.
• Accurate diagnosis is crucial to prevent misclassification and ensure appropriate management for patients with lipodystrophy or Cushing's syndrome.